Variant report
Variant | nsv594809 |
---|---|
Chromosome Location | chr4:90123667-90132470 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TIGD2-5 | chr4:90124197-90124233 | NONHSAT097385 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6821473 | chr4:90123667-90123668 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs180964182 | chr4:90123726-90123727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116186488 | chr4:90123729-90123730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs367723132 | chr4:90123749-90123750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs372338193 | chr4:90123773-90123774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs11940451 | chr4:90123790-90123791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs185387195 | chr4:90123815-90123816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs565883013 | chr4:90123816-90123817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs556390094 | chr4:90123851-90123852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536224891 | chr4:90123863-90123864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554578426 | chr4:90123871-90123872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6821885 | chr4:90123877-90123878 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs115167142 | chr4:90123881-90123882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558422395 | chr4:90123896-90123897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs576979127 | chr4:90123931-90123932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs2195754 | chr4:90123947-90123948 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs559466731 | chr4:90124009-90124010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372081443 | chr4:90124013-90124014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188738876 | chr4:90124047-90124048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2195755 | chr4:90124057-90124058 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs181702195 | chr4:90124064-90124065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs548010748 | chr4:90124083-90124084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371552174 | chr4:90124088-90124089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550457880 | chr4:90124154-90124155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565479227 | chr4:90124182-90124183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532738471 | chr4:90124189-90124190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547613976 | chr4:90124198-90124199 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs6822518 | chr4:90124260-90124261 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs536362908 | chr4:90124276-90124277 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548152948 | chr4:90124298-90124299 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs13117235 | chr4:90124387-90124388 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs114291385 | chr4:90124394-90124395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs150104160 | chr4:90124408-90124409 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs186825788 | chr4:90124464-90124465 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs16996178 | chr4:90124467-90124468 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs372316654 | chr4:90124531-90124532 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs693575 | chr4:90124558-90124559 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs191592934 | chr4:90124563-90124564 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs530401021 | chr4:90124593-90124594 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183942225 | chr4:90124620-90124621 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186489189 | chr4:90124631-90124632 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570367627 | chr4:90124642-90124643 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs693664 | chr4:90124643-90124644 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs695053 | chr4:90124654-90124655 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs545526660 | chr4:90124678-90124679 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs565551439 | chr4:90124846-90124847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs72869823 | chr4:90124847-90124848 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs80007183 | chr4:90124852-90124853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559545567 | chr4:90124912-90124913 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs530091583 | chr4:90124972-90124973 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Obesity | 20622171 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:90117800-90127800 | Weak transcription | Pancreas | Pancrea |
2 | chr4:90122000-90125200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
3 | chr4:90124200-90125000 | Enhancers | Gastric | stomach |
4 | chr4:90125000-90127200 | Enhancers | Hela-S3 | cervix |
5 | chr4:90125200-90125400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
6 | chr4:90125400-90126400 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
7 | chr4:90125800-90126400 | Enhancers | A549 | lung |
8 | chr4:90126000-90126600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr4:90126400-90127000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
10 | chr4:90127800-90128000 | ZNF genes & repeats | Pancreas | Pancrea |
11 | chr4:90128000-90142400 | Weak transcription | Pancreas | Pancrea |
12 | chr4:90132400-90132600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |